Canada · Delayed Price · Currency is CAD Anaergia Earnings Call Transcripts
Fiscal Year 2025
-
Record revenue and gross profit growth in 2025, with positive Adjusted EBITDA and a doubled revenue backlog. Strong commercial momentum, improved margins, and expanding global demand position the company for continued growth in 2026.
-
Q3 2025 marked a financial turnaround with revenue up 77% year-over-year, positive adjusted EBITDA, and a record $287 million backlog. Growth was driven by strong capital sales in Europe and North America, with margin expansion and operational efficiency supporting future outlook.
-
Q2 2025 saw revenue rise 36.8% year-over-year to $32.3 million, with gross margin up to 32.5% and backlog more than doubling since year-end. Expanded contracts in Europe and North America and disciplined execution drove improved profitability and a robust project pipeline.
-
Revenue was stable at CAD 24.9 million with a significant improvement in net loss and adjusted EBITDA. Backlog nearly doubled year-over-year to CAD 200 million, driven by major contract wins in Europe and North America, and margins in capital sales strengthened.
Fiscal Year 2024
-
2024 saw foundational changes, a $41M investment, and a shift to a capital light model, driving improved margins and a 71% reduction in net loss. Major contract wins and a $103.3M backlog position the company for sustainable growth in 2025.
-
Leadership changes and a shift to a capital-light model drove improved EBITDA and reduced losses, despite lower revenue. Strong cash position, robust project pipeline, and expanding global presence position the company for profitable growth in 2025 and beyond.